Skip to main content

ECCMID2018

You are here

ECCMID 2018

Date 21 April 2018 to 24 April 2018

Location Madrid, Spain

Novosanis will attend the 28th European Congress of Clinical Microbiology and Infectious Diseases, which will take place in Madrid, Spain, from 21 - 24 April 2018. Here the world’s leading experts will join the most important congress in infectious diseases, infection control and clinical microbiology to present and discuss the latest results.

Check out our poster on Zika virus in urine and serum samples on Monday April 23 at 12.30 CET (Poster #P1342).

Our CEO Vanessa Vankerckhoven, CTO Koen Beyers, Sales & BusDev Director Jeane Brunmark and Clinical Affairs Manager Timothi Van Mulder look forward to meeting you and discuss possibility for collaboration for our self-sampling device, Colli-Pee as well as our drug delivery device, VAX-ID.

ECCMID2018

Disclaimer

Novosanis is a wholly owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology. The Colli-Pee® family, the heart of the company, allows volumetric and standardized collection of first-void urine. The platform consists of variants capturing a range of urine volumes for different application purposes. Urine collection through the Colli-Pee® device is easy, comfortable, and more accurate than a regular urine cup. First-void urine has shown to improve detection of infectious diseases, including sexually transmitted infections as well as for some cancers applications. The Colli-Pee® device enables immediate mixing of the first-void urine sample with a preservative, improving stability of the urine specimen. Novosanis markets its products worldwide and has a global customer base.

2024 © Novosanis, a subsidiary of OraSure Technologies, Inc., all rights reserved.